(±) -Zanubrutinib
(±) -Zanubrutinib ((±) -BGB-3111) is the racemate of Zanubrutinib (HY-101474A) . (±) -Zanubrutinib inhibits Bruton's tyrosine kinase (Btk) with an IC50 of 0.63 nM[1].
Product Specifications
CAS Number
[1633350-06-7]
Product Name Alternative
(±) -BGB-3111
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
Btk
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/BGB-3111.html
Purity
99.70
Solubility
DMSO : ≥ 30 mg/mL|Ethanol : ≥ 10 mg/mL
Smiles
NC(C1=C2N(N=C1C3=CC=C(OC4=CC=CC=C4)C=C3)C(C5CCN(C(C=C)=O)CC5)CCN2)=O
Molecular Formula
C27H29N5O3
Molecular Weight
471.55
Precautions
H315, H319, H335
References & Citations
[1]Na L, et al. BGB-3111 is a novel and highly selective Bruton's tyrosine kinase (BTK) inhibitor. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA) : AACR; Cancer Res 2015;75 (15 Suppl) :Abstract nr 2597. doi:10.1158/1538-7445.AM2015-2597
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
